Skip to main content
. 2019 Jun 26;11(6):347–374. doi: 10.4252/wjsc.v11.i6.347

Figure 5.

Figure 5

qPCR analysis for pluripotency and the genetic stability of mesenchymal stem cell. mRNA for Sox2 and Oct4 characterizes the pluripotency of MSCs, tumor suppressor gene p53, and proto-oncogenes c-Myc expression for the genetic stability of BM-MSCs, AT-MSCs, SM-derived stem/progenitor cells (SM-MSCs) and SK-MSCs as compared to iPSC control and to an early passage, P1. (*P < 0.05, **P < 0.005, ***P < 0.0001). BM-MSC: Bone marrow - mesenchymal stem cell; AT-MSC: Adipose tissue - mesenchymal stem cell; SK-MSC: Skin - mesenchymal stem cell; SM-MSC: Skeletal muscle - mesenchymal stem cell.